Steven A. Stacker

Citado por

	Total	Desde 2019
Citas	29915	5835
Índice h	82	40
Índice i10	166	93

1500

750

375

1125

1990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202479 87 240 312 266 243 233 238 331 360 400 554 706 808 1006 1106 1385 1367 1472 1363 1253 1331 1295 1372 1347 1129 1314 1084 1082 1015 1178 1271 1070 992 309

Acceso público

Ver todo

53 artículos

6 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Marc G AchenPeter MacCallum Cancer Centre, Melbourne, AustraliaDirección de correo verificada de petermac.org
Tara karnezisSt Vincent’s instituteDirección de correo verificada de svi.edu.au
Margaret L HibbsAssociate Professor, Monash UniversityDirección de correo verificada de monash.edu
ramin shayanPlastic Surgeon | Director, O’Brien Institute, St Vincent’s InstituteDirección de correo verificada de svi.edu.au
Ed NiceDepartment of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, AustraliaDirección de correo verificada de monash.edu
Timothy SpringerHarvard Medical School, Childrens Hospital BostonDirección de correo verificada de crystal.harvard.edu
Stephen FoxMelbourneDirección de correo verificada de petermac.org
Tuomas Rissanen, MD, PhD, DocentCentral Hospital of North Karelia, Joensuu, FinlandDirección de correo verificada de siunsote.fi
Lyn WiseUniversity of OtagoDirección de correo verificada de otago.ac.nz
Michael JeltschUniversity of HelsinkiDirección de correo verificada de helsinki.fi
Benjamin M. HoganProfessor, Peter MacCallum Cancer Centre and University of MelbourneDirección de correo verificada de petermac.org
Jackson DGProfessor of Human Immunology University of OxfordDirección de correo verificada de imm.ox.ac.uk
Neil I. BowerResearch Officer, Institute for Molecular Bioscience, University of Queensland, AustraliaDirección de correo verificada de uq.edu.au
Sophie Paquet-FifieldMelbourneDirección de correo verificada de unimelb.edu.au
Cameron NowellMonash UniversityDirección de correo verificada de monash.edu
C M HovensVictorian Comprehensive Cancer Center, Department of Surgery University of MelbourneDirección de correo verificada de unimelb.edu.au
Donald M McDonaldUniversity of California San FranciscoDirección de correo verificada de ucsf.edu
Mark CooperDepartment of Diabetes, Monash UniversityDirección de correo verificada de monash.edu
Richard E. GilbertUniversity of Melbourne, St. Michael's Hospital, Austin, Guy'sDirección de correo verificada de utoronto.ca
Erica SloanAssociate ProfessorDirección de correo verificada de monash.edu

Seguir

Steven A. Stacker

Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, University of Melbourne, Australia

Dirección de correo verificada de petermac.org

Angiogenesis lymphangiogenesis growth factors receptors


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics SA Stacker, C Caesar, ME Baldwin, GE Thornton, RA Williams, R Prevo, ... Nature medicine 7 (2), 186-191, 2001	1840	2001
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) MG Achen, M Jeltsch, E Kukk, T Mäkinen, A Vitali, AF Wilks, K Alitalo, ... Proceedings of the National Academy of Sciences 95 (2), 548-553, 1998	1688	1998
ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). MS Diamond, DE Staunton, AR de Fougerolles, SA Stacker, ... The Journal of cell biology 111 (6), 3129-3139, 1990	1166	1990
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3 T Mäkinen, T Veikkola, S Mustjoki, T Karpanen, B Catimel, EC Nice, ... The EMBO journal, 2001	1131	2001
Lymphangiogenesis and cancer metastasis SA Stacker, MG Achen, L Jussila, ME Baldwin, K Alitalo Nature Reviews Cancer 2 (8), 573-583, 2002	1049	2002
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice T Veikkola, L Jussila, T Makinen, T Karpanen, M Jeltsch, TV Petrova, ... The EMBO journal 20 (6), 1223-1231, 2001	920	2001
Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease ML Hibbs, DM Tarlinton, J Armes, D Grail, G Hodgson, R Maglitto, ... Cell 83 (2), 301-311, 1995	881	1995
Lymphangiogenesis and lymphatic vessel remodelling in cancer SA Stacker, SP Williams, T Karnezis, R Shayan, SB Fox, MG Achen Nature Reviews Cancer 14 (3), 159-172, 2014	812	2014
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. AR de Fougerolles, SA Stacker, R Schwarting, TA Springer The Journal of experimental medicine 174 (1), 253-267, 1991	709	1991
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation P Baluk, T Tammela, E Ator, N Lyubynska, MG Achen, DJ Hicklin, ... The Journal of clinical investigation 115 (2), 247-257, 2005	698	2005
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. ME Cooper, D Vranes, S Youssef, SA Stacker, AJ Cox, B Rizkalla, ... Diabetes 48 (11), 2229-2239, 1999	676	1999
Sox18 induces development of the lymphatic vasculature in mice M Francois, A Caprini, B Hosking, F Orsenigo, D Wilhelm, C Browne, ... Nature 456 (7222), 643-647, 2008	593	2008
Inhibition of Growth of C6 Glioma Cells in Vivo by Expression of Antisense Vascular Endothelial Growth Factor Sequence M Saleh, SA Stacker, AF Wilks Cancer research 56 (2), 393-401, 1996	576	1996
Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018	553	2018
VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses TT Rissanen, JE Markkanen, M Gruchala, T Heikura, A Puranen, ... Circulation research 92 (10), 1098-1106, 2003	538	2003
VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues TA Partanen, J Arola, A Saaristo, L Jussila, A Ora, M Miettinen, SA Stacker, ... The FASEB Journal 14 (13), 2087-2096, 2000	499	2000
Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers SA Stacker, K Stenvers, C Caesar, A Vitali, T Domagala, E Nice, S Roufail, ... Journal of Biological Chemistry 274 (45), 32127-32136, 1999	448	1999
Focus on lymphangiogenesis in tumor metastasis MG Achen, BK McColl, SA Stacker Cancer cell 7 (2), 121-127, 2005	437	2005
The role of tumor lymphangiogenesis in metastatic spread SA Stacker, ME Baldwin, MG Achen The FASEB Journal 16 (9), 922-934, 2002	436	2002
Vascular endothelial growth factor D is dispensable for development of the lymphatic system ME Baldwin, MM Halford, S Roufail, RA Williams, ML Hibbs, D Grail, ... Molecular and cellular biology, 2005	415	2005

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores